Physician profile
Steven Albert Stanten
NPI 1285697698
$51,776.21
in general payments reported to CMS, 2019-2025
37 companies · $5,171 in 2025
The $5,171 reported for 2025 was more than what 91% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12K · 2020: $6,637 · 2021: $3,372 · 2022: $17K · 2023: $5,500 · 2024: $2,460 · 2025: $5,171.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $7,688 · Food and Beverage: $3,881 · Travel and Lodging: $1,562.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $7,687.50 |
| Food and Beverage | $3,881.16 |
| Travel and Lodging | $1,561.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Applied Medical Resources Corporation | $39,774.36 | 2019-2025 | |
| Intuitive Surgical, INC. | $6,177.60 | 2019-2025 | Da Vinci Surgical System, Davinci Xi |
| Medtronic, INC. | $2,438.05 | 2021-2025 | Signia, Ligasure, V-Loc 180 |
| Ethicon US, LLC | $430.71 | 2019-2025 | Echelon Circular, Echelon; Endopath, Vistaseal |
| Tela Bio, INC. | $390.47 | 2020-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Covidien LP | $311.09 | 2019-2020 | |
| Heron Therapeutics, INC. | $282.28 | 2022 | |
| Davol INC. | $265.82 | 2020-2025 | Phasix Mesh |
| Integra Lifesciences Corporation | $250.20 | 2021-2025 | Integra, Integra Dermal Regeneration Template, Surgimend |
| Medical Device Business Services, INC. | $244.86 | 2019-2023 | Vistaseal |
| Conmed Corporation | $125.00 | 2020 | |
| Teleflex LLC | $121.64 | 2021-2024 | Titan Sgs |
| Acell, INC. | $113.40 | 2019-2020 | |
| Abbvie INC. | $88.82 | 2019-2020 | |
| Avanos Medical | $77.00 | 2022-2023 | On-Q* Pump and Accessories |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $62.33 | 2024-2025 | Gore Synecor Biomaterial |
| Vertex Pharmaceuticals Incorporated | $55.24 | 2025 | |
| Boston Scientific Corporation | $53.20 | 2023 | Spyglass |
| Allergan, INC. | $52.82 | 2019-2022 | |
| Amgen INC. | $45.26 | 2019 | |
| Baxter Healthcare | $43.29 | 2019-2020 | |
| Ambu INC. | $38.25 | 2024 | |
| Pacira Pharmaceuticals Incorporated | $37.93 | 2019-2020 | |
| Endo Pharmaceuticals INC. | $36.26 | 2019-2020 | |
| Ethicon Endo-Surgery INC. | $30.27 | 2019 | |
| Braintree Laboratories, INC. | $27.79 | 2025 | Suflave, Sutab |
| Coloplast Corp | $27.45 | 2020 | |
| Biocompatibles, INC. | $23.18 | 2019 | |
| Vioptix INC | $21.90 | 2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $20.54 | 2022 | |
| Bsn Medical INC | $19.54 | 2019 | |
| Mimedx Group, INC. | $18.88 | 2024 | |
| Daiichi Sankyo INC. | $16.11 | 2019 | |
| Getinge USA Sales, LLC | $15.67 | 2024 | Cardiosave Hybrid, Type B Plug |
| Ferring Pharmaceuticals INC. | $14.38 | 2022 | |
| Merck Sharp & Dohme LLC | $13.52 | 2019 | |
| Kyowa Kirin, INC. | $11.10 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Stanten listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.